During the last session, Conduit Pharmaceuticals Inc (NASDAQ:CDT)’s traded shares were 72.49 million, with the beta value of the company hitting 2.29. At the end of the trading day, the stock’s price was $0.06, reflecting an intraday loss of -7.41% or -$0.01. The 52-week high for the CDT share is $3.92, that puts it down -6433.33 from that peak though still a striking 16.67% gain since the share price plummeted to a 52-week low of $0.05. The company’s market capitalization is $9.61M, and the average intraday trading volume over the past 10 days was 186.41 million shares, and the average trade volume was 51.59 million shares over the past three months.
Conduit Pharmaceuticals Inc (NASDAQ:CDT) trade information
Conduit Pharmaceuticals Inc (CDT) registered a -7.41% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -7.41% in intraday trading to $0.06, hitting a weekly high. The stock’s 5-day price performance is -32.07%, and it has moved by -11.97% in 30 days. Based on these gigs, the overall price performance for the year is -97.81%. The short interest in Conduit Pharmaceuticals Inc (NASDAQ:CDT) is 3.57 million shares and it means that shorts have 0.14 day(s) to cover.
CDT Dividends
Conduit Pharmaceuticals Inc is due to release its next quarterly earnings in February. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Conduit Pharmaceuticals Inc (NASDAQ:CDT)’s Major holders
Conduit Pharmaceuticals Inc insiders own 49.12% of total outstanding shares while institutional holders control 4.06%, with the float percentage being 7.97%.
Also, the Mutual Funds coming in first place with the largest holdings of Conduit Pharmaceuticals Inc (CDT) shares are Fidelity Small Cap Index Fund and Vanguard Extended Market Index Fund . Data provided on Oct 31, 2024 indicates that Fidelity Small Cap Index Fund owns about 233.35 shares. This amounts to just over 0.19 percent of the company’s overall shares, with a $14584.0 market value. The same data shows that the other fund manager holds slightly less at 202.93, or about 0.17% of the stock, which is worth about $12683.0.
